CEO of Everest Medicines, Rogers Yongqing Luo, is confident that the appointments of Ms. Zeng and Mr. Liang will expedite the company's strategic growth. They are anticipated to spearhead their teams and foster strategic integration, promoting successful commercialization of Everest's products and long-term value creation.
$恒生指数(800000.HK)$plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion. Pharmaceuticals were sold off.$荣昌生物(09995.HK)$once collapsed 27.5% to $22.8; last at $24.9, down 21%. $三叶草生物-B(02197.HK)$nosedived 9.6% to $0.47, hitting record low.$维亚生物(01873.HK)$...
$云顶新耀-B(01952.HK)$On September 13, Genting Sunshine announced that it would introduce Providence's mRNA COVID-19 vaccine at a total price of 2.583 billion yuan, and the two parties will also cooperate in the development of two mRNA vaccines in the future.
1
1
举报
102252270 :
ia there any positive update about everest?
云顶新耀-B股票讨论区
HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off
Pharmaceuticals were sold off. $荣昌生物(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$三叶草生物-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $维亚生物(01873.HK)$ ...
暂无评论